Head and Neck Cancer Therapeutics Market: Immunotherapy Reshapes a Difficult Disease
Head and neck cancers — including cancers of the oral cavity, pharynx, larynx, and salivary glands — represent a substantial global disease burden. Historically, treatment relied on surgery, radiotherapy, and chemotherapy, with limited options for recurrent or metastatic disease. The arrival of immunotherapy and targeted agents has begun to change this picture, and the head and neck...
0 Commentarios 0 Acciones 5 Views 0 Vista previa